ABMD Abiomed, Inc. Stock Quote

ABMD [NASD]

Index	S&P 500	P/E	85.60	EPS (ttm)	2.96	Insider Own	1.20%	Shs Outstand	45.51M	Perf Week	8.41%
Market Cap	10.65B	Forward P/E	44.90	EPS next Y	5.65	Insider Trans	-10.38%	Shs Float	44.58M	Perf Month	-17.08%
Income	136.50M	PEG	22.41	EPS next Q	1.05	Inst Own	95.40%	Short Float	2.52%	Perf Quarter	-12.62%
Sales	1.03B	P/S	10.32	EPS this Y	11.40%	Inst Trans	1.40%	Short Ratio	3.93	Perf Half Y	-29.68%
Book/sh	31.49	P/B	8.06	EPS next Y	24.41%	ROA	9.80%	Target Price	354.17	Perf Year	-5.28%
Cash/sh	15.95	P/C	15.91	EPS next 5Y	3.82%	ROE	10.90%	52W Range	227.25 - 379.30	Perf YTD	-29.34%
Dividend	-	P/FCF	45.66	EPS past 5Y	42.20%	ROI	12.50%	52W High	-33.09%	Beta	1.40
Dividend %	-	Quick Ratio	6.30	Sales past 5Y	20.80%	Gross Margin	81.80%	52W Low	11.68%	ATR	14.81
Employees	1725	Current Ratio	7.00	Sales Q/Q	12.70%	Oper. Margin	14.10%	RSI (14)	39.67	Volatility	5.52% 5.65%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-26.40%	Profit Margin	14.50%	Rel Volume	0.97	Prev Close	254.16
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Apr 28 BMO	Payout	0.00%	Avg Volume	285.35K	Price	253.79
Recom	2.50	SMA20	-9.23%	SMA50	-14.80%	SMA200	-21.54%	Volume	291,730	Change	-0.15%

Apr-06-22

Initiated

Wolfe Research

Peer Perform

$330

Jun-18-21

Initiated

Deutsche Bank

Buy

$360

Apr-27-20

Downgrade

SVB Leerink

Outperform → Mkt Perform

$175

Feb-12-20

Downgrade

Morgan Stanley

Equal-Weight → Underweight

$165

Feb-06-20

Resumed

BTIG Research

Neutral

Oct-29-19

Downgrade

Raymond James

Outperform → Mkt Perform

Aug-02-19

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$325 → $215

Aug-02-19

Downgrade

Guggenheim

Buy → Neutral

Aug-01-19

Downgrade

BTIG Research

Buy → Neutral

Nov-07-18

Upgrade

Morgan Stanley

Equal-Weight → Overweight

Nov-02-18

Upgrade

BTIG Research

Neutral → Buy

Jun-22-18

Reiterated

Piper Jaffray

Overweight

$360 → $480

Apr-04-18

Initiated

Goldman

Buy

$332

Jan-19-18

Reiterated

Leerink Partners

Outperform

$200 → $265

Oct-16-17

Downgrade

BTIG Research

Buy → Neutral

Sep-29-17

Initiated

SunTrust

Buy

$195

Jun-08-17

Resumed

William Blair

Outperform

Apr-06-17

Upgrade

Piper Jaffray

Neutral → Overweight

Dec-07-16

Initiated

Guggenheim

Buy

Oct-30-15

Upgrade

Raymond James

Mkt Perform → Outperform

May-16-22 10:48AM	Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now Zacks
May-12-22 09:45AM	Why Abiomed (ABMD) is a Top Growth Stock for the Long-Term Zacks
May-08-22 10:40AM	Should Weakness in Abiomed, Inc.'s (NASDAQ:ABMD) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? Simply Wall St.
May-02-22 08:37AM	Integra (IART) Q1 Earnings Top Estimates, Margins Expand Zacks
Apr-29-22 10:30AM	QIAGEN (QGEN) Q1 Earnings Surpass Estimates, 2022 View Up Zacks
Apr-28-22 08:52AM	Abiomed (ABMD) Q4 Earnings and Revenues Surpass Estimates Zacks
07:00AM	Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year Business Wire
Apr-27-22 07:15AM	Integra LifeSciences (IART) Tops Q1 Earnings and Revenue Estimates Zacks
07:13AM	MedTech Stocks' Apr 28 Earnings Roster: ABMD, SYK & More Zacks
Apr-26-22 08:02AM	Worlds First Patient Implanted with Impella BTR Minimally Invasive Heart Pump Business Wire -5.38%
Apr-22-22 11:55AM	Here's Why You Should Retain Allscripts (MDRX) Stock For Now Zacks -6.28%
11:16AM	Abiomed (ABMD) to Report Q4 Earnings: What's in the Cards? Zacks
11:12AM	Here's Why You Should Retain Integra (IART) Stock For Now Zacks
11:05AM	Globus Medical (GMED) Stock Fell on Preliminary Q1 Sales Results Zacks
Apr-21-22 10:35AM	Here's Why You Should Retain Baxter (BAX) Stock For Now Zacks
09:17AM	Here's Why You Should Retain Cardinal Health (CAH) Stock Now Zacks
Apr-20-22 12:19PM	Reasons to Add AMN Healthcare (AMN) Stock to Your Portfolio Zacks
10:13AM	Here's Why You Should Hold on to Illumina (ILMN) Stock For Now Zacks
08:52AM	Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now Zacks
06:21AM	Zacks Industry Outlook Highlights Alcon, STERIS and Abiomed Zacks
Apr-19-22 11:44AM	Merit Medical's (MMSI) Latest Launch to Boost Patient Outcome Zacks +7.27%
10:19AM	Here's Why You Should Retain Bio-Rad (BIO) Stock For Now Zacks
10:17AM	Patterson Companies (PDCO) Moves Up 12.5%: What's Driving It? Zacks
10:14AM	Thermo Fisher (TMO) Debuts GMP-Manufactured Cas9 Protein Zacks
09:32AM	Here's Why You Should Hold on to CONMED (CNMD) Stock Now Zacks
08:51AM	3 Medical Instruments Stocks to Buy Despite Industry Headwinds Zacks
Apr-18-22 10:36AM	McKesson (MCK) Hits 52-Week High: What's Aiding the Stock? Zacks
09:59AM	Catalent's (CTLT) Latest Manufacturing Suites to Boost Capacity Zacks
09:38AM	Henry Schein (HSIC) Stock Moves Up 20.6%: What's Driving It? Zacks
09:33AM	Here's Why You Should Hold on to Insulet (PODD) Stock For Now Zacks
09:31AM	Here's Why You Should Retain Zimmer Biomet (ZBH) Stock For Now Zacks
07:46AM	Here's Why You Should Retain PerkinElmer (PKI) Stock Now Zacks
Apr-14-22 10:29AM	Here's Why You Should Hold on to Haemonetics (HAE) For Now Zacks
10:04AM	DexCom (DXCM) G6 CGM System Now Available to TRICARE Members Zacks
09:33AM	Fresenius Medical (FMS) Launches Campaign to Boost Kidney Care Zacks
08:44AM	Illumina (ILMN) Hurt by Rising Costs, Tough Competition Zacks
Apr-13-22 10:09AM	NEOGEN (NEOG) Adds to Prozap Insect Control Product Line-up Zacks
10:07AM	Here's Why You Should Hold on to Cardiovascular Systems (CSII) Zacks
Apr-12-22 10:46AM	IDEXX (IDXX) CAG Sales Gain Traction, FX Headwind Persists Zacks
10:42AM	Here's Why You Should Retain Boston Scientific (BSX) For Now Zacks
10:01AM	Here's Why You Should Retain Thermo Fisher (TMO) For Now Zacks
Apr-11-22 01:14PM	Abiomed (ABMD) Announces Successful Usage of Impella in Japan Zacks
10:18AM	STERIS (STE) Up 8% Since Q3 Earnings: What's Driving It? Zacks
08:54AM	Here's Why You Should Retain Charles River (CRL) Stock For Now Zacks
Apr-08-22 10:00AM	AngioDynamics (ANGO) Q3 Earnings Top Estimates, Revenues Lag Zacks
07:00AM	Abiomed Fourth Quarter Fiscal 2022 Earnings and Conference Call Notification Business Wire
Apr-06-22 08:04AM	First Patient in Japan Treated with Impella 5.5 with SmartAssist Business Wire
Apr-05-22 07:46AM	7 Medical Device Stocks to Buy as Covid-19 Fears Fade InvestorPlace
Apr-04-22 05:05PM	Buy the Dip: Digital Turbine, Abiomed, Palo Alto Networks TheStreet.com
Mar-29-22 09:33AM	Abiomed Could Soon Rally So Look to Buy a Minor Dip TheStreet.com
Mar-21-22 07:00AM	Abiomed to Host Investor Call on Impella ECP, the Worlds Smallest Heart Pump at 9 French Business Wire
Mar-16-22 11:51AM	Returns At Abiomed (NASDAQ:ABMD) Appear To Be Weighed Down Simply Wall St.
Mar-15-22 12:55PM	Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now Zacks
Mar-12-22 10:45AM	Got $5,000? 3 Growth Stocks to Buy That Could Double Your Money Motley Fool
Mar-07-22 09:10AM	Is Abiomed (ABMD) A Great Investment to Take? Insider Monkey
Feb-11-22 10:55AM	Here's Why You Should Retain Abiomed (ABMD) Stock For Now Zacks
Feb-08-22 04:05PM	Abiomed to Present at the SVB Leerink 11th Annual Global Healthcare Conference Business Wire +6.62%
Feb-03-22 01:09PM	Abiomed (ABMD) Beats on Q3 Earnings, Narrows FY22 Guidance Zacks -5.66%
08:35AM	Abiomed (ABMD) Q3 Earnings and Revenues Top Estimates Zacks
07:00AM	Abiomed Announces Record Revenue of $261 Million, up 13% Year Over Year Business Wire
Jan-30-22 06:38AM	These 4 Measures Indicate That Abiomed (NASDAQ:ABMD) Is Using Debt Safely Simply Wall St.
Jan-28-22 09:19AM	Abiomed (ABMD) to Report Q3 Earnings: What's in the Cards? Zacks
Jan-27-22 03:01PM	Analysts Estimate Abiomed (ABMD) to Report a Decline in Earnings: What to Look Out for Zacks -6.68%
Jan-24-22 11:32AM	Stryker (SYK) to Report Q4 Earnings: What's in the Cards? Zacks
Jan-21-22 09:38PM	Conestoga Capital Advisors, LLC Buys Paycor HCM Inc, Definitive Healthcare Corp, Q2 Holdings ... GuruFocus.com
Jan-20-22 12:10PM	Why Abiomed (ABMD) Could Beat Earnings Estimates Again Zacks
Jan-19-22 05:38PM	West Coast Financial LLC Buys Schwab Short-Term U.S. Treasury ETF, Schwab Intermediate-Term U.S. ... GuruFocus.com
11:39AM	Abiomed (ABMD) Reports Positive Data Backing preCARDIA System Zacks
Jan-14-22 07:00AM	Abiomed Third Quarter Fiscal 2022 Earnings and Conference Call Notification Business Wire
Jan-12-22 11:51AM	Here's Why You Should Retain Abiomed (ABMD) Stock For Now Zacks
08:03AM	Early Feasibility Study Demonstrates Successful Use of Abiomeds preCARDIA Technology Business Wire
Jan-11-22 05:20PM	Why Holding Anthem (ANTM) in Your Portfolio is a Prudent Move? Zacks
Jan-10-22 10:19AM	Here's Why You Should Retain Intuitive Surgical (ISRG) Stock Zacks
10:17AM	PacBio's (PACB) Sequel IIe Boosts Radboudumc's Sequencing Ability Zacks
08:02AM	Regulators Approve Impella 5.5 With SmartAssist in Japan and Hong Kong; US FDA Grants Impella BTR Conditional IDE Approval for First-in-Human Early Feasibility Study Business Wire
Jan-07-22 04:41PM	Stryker (SYK) to Boost Digital Capabilities With New Buyout Zacks -5.10%
10:51AM	AngioDynamics (ANGO) Q2 Earnings Lag Estimates, Revenues Top Zacks
Jan-06-22 12:03PM	Here's Why You Should Retain Stryker (SYK) Stock Right Now Zacks
11:58AM	PacBio (PACB) Ties Up to Boost Rare Disease Diagnosis in Canada Zacks
Jan-05-22 01:38PM	Hall Laurie J Trustee Buys Nestle SA, Trex Co Inc, Tesla Inc, Sells First Republic Bank, ... GuruFocus.com -6.47%
10:30AM	Here's Why You Should Retain Cardinal Health (CAH) Stock Now Zacks
10:28AM	Nevro's (NVRO) 10 kHz Therapy for Treatment of PDN Gets Coverage Zacks
09:35AM	Here's Why You Should Hold on to Bruker (BRKR) Stock for Now Zacks
07:59AM	Illumina (ILMN) Ties Up With Syapse to Evaluate Biomarker Testing Zacks
Jan-04-22 09:46AM	Here's Why You Should Retain LHC Group (LHCG) Stock Now Zacks
Dec-30-21 09:40AM	Has Abiomed (ABMD) Outpaced Other Medical Stocks This Year? Zacks
Dec-29-21 07:00AM	Abiomed to Present at the 40th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-16-21 04:26AM	Abiomed (NASDAQ:ABMD) shareholders have earned a 23% CAGR over the last five years Simply Wall St.
Dec-12-21 09:36PM	Is ABIOMED, Inc. (ABMD) Going to Burn These Hedge Funds? Insider Monkey
Dec-06-21 11:15AM	Here's Why You Should Retain Abiomed (ABMD) Stock for Now Zacks
Nov-18-21 07:00AM	Abiomed to Present at Upcoming Investor Conferences Business Wire
Nov-04-21 08:05AM	Two Large Studies Demonstrate Complete Revascularization with Impella Heart Pumps Improves Ejection Fraction and Long-Term Patient Outcomes Business Wire
Nov-03-21 08:02AM	Impella Advances to Higher Level of Recommendation in Newest ESC Guidelines Business Wire
Nov-01-21 07:58AM	TCT 2021 to Highlight Improved Patient Outcomes with Impellas Small, Smart and Connected Technology Business Wire +5.41%
06:08AM	Will Weakness in Abiomed, Inc.'s (NASDAQ:ABMD) Stock Prove Temporary Given Strong Fundamentals? Simply Wall St.
Oct-28-21 02:00PM	ABIOMED, inc (ABMD) Q2 2022 Earnings Call Transcript Motley Fool
09:22AM	Abiomed (ABMD) Beats on Q2 Earnings, Lowers FY22 Guidance Zacks
09:15AM	Abiomed (ABMD) Q2 Earnings Beat Estimates Zacks
07:00AM	Abiomed Announces Q2 FY 2022 Revenue of $248 Million, Up 18% Year Over Year Business Wire
Oct-25-21 03:27PM	Is ABIOMED, Inc. (ABMD) A Good Stock To Buy? Insider Monkey

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the Automated Impella Controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; and Impella BTR, a percutaneous micro heart pump with integrated motors and sensors. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Trapp Todd A	VICE PRESIDENT, CFO	Apr 04	Sale	333.00	1,000	333,000	13,063	Apr 06 04:26 PM
Weber David M	CHIEF OPERATING OFFICER	Mar 31	Sale	340.00	7,500	2,550,000	116,314	Apr 04 05:07 PM
SUTTER MARTIN P	Director	Feb 17	Sale	314.71	4,000	1,258,852	130,390	Feb 17 06:13 PM
Weber David M	Chief Operating Officer	Feb 16	Sale	325.00	7,500	2,437,500	123,814	Feb 18 04:10 PM
SUTTER MARTIN P	Director	Feb 16	Sale	308.66	2,000	617,322	134,390	Feb 17 06:12 PM
SUTTER MARTIN P	Director	Feb 15	Sale	303.65	2,000	607,301	136,390	Feb 17 06:11 PM
Weber David M	Chief Operating Officer	Feb 09	Option Exercise	21.55	3,112	67,064	134,426	Feb 09 05:43 PM
Weber David M	Chief Operating Officer	Feb 09	Sale	310.19	3,112	965,311	131,314	Feb 09 05:43 PM
Weber David M	Chief Operating Officer	Feb 08	Option Exercise	21.55	7,413	159,750	138,727	Feb 09 05:43 PM
Weber David M	Chief Operating Officer	Feb 08	Sale	302.90	7,413	2,245,423	131,314	Feb 09 05:43 PM
Weber David M	Chief Operating Officer	Feb 07	Option Exercise	21.55	300	6,465	131,614	Feb 09 05:43 PM
Weber David M	Chief Operating Officer	Feb 07	Sale	300.25	300	90,076	131,314	Feb 09 05:43 PM
Trapp Todd A	Vice President, CFO	Jan 05	Sale	359.43	1,000	359,430	14,063	Jan 07 04:27 PM
SUTTER MARTIN P	Director	Nov 18	Sale	338.59	15,000	5,078,787	138,390	Nov 18 04:45 PM
SUTTER MARTIN P	Director	Nov 17	Sale	344.95	3,750	1,293,573	153,390	Nov 18 04:45 PM
SUTTER MARTIN P	Director	Nov 16	Sale	351.85	3,750	1,319,448	157,140	Nov 18 04:45 PM
MINOGUE MICHAEL R	Chairman, President, CEO	Aug 23	Option Exercise	23.15	3,492	80,840	215,127	Aug 25 04:37 PM
MINOGUE MICHAEL R	Chairman, President, CEO	Aug 23	Sale	350.00	3,492	1,222,200	211,635	Aug 25 04:37 PM
THOMAS PAUL	Director	Aug 18	Sale	330.77	663	219,301	6,908	Aug 19 04:17 PM
SUTTER MARTIN P	Director	Aug 18	Sale	332.90	3,750	1,248,373	161,890	Aug 19 04:16 PM
SUTTER MARTIN P	Director	Aug 17	Sale	326.73	3,750	1,225,250	165,640	Aug 19 04:16 PM
MINOGUE MICHAEL R	Chairman, President, CEO	Aug 09	Option Exercise	23.15	7,037	162,907	218,672	Aug 10 05:07 PM
MINOGUE MICHAEL R	Chairman, President, CEO	Aug 09	Sale	350.00	7,037	2,462,950	211,635	Aug 10 05:07 PM
MINOGUE MICHAEL R	Chairman, President, CEO	Aug 06	Option Exercise	23.15	24,471	566,504	236,106	Aug 10 05:07 PM
MINOGUE MICHAEL R	Chairman, President, CEO	Aug 06	Sale	350.00	24,471	8,564,850	211,635	Aug 10 05:07 PM
MINOGUE MICHAEL R	Chairman, President, CEO	Aug 05	Option Exercise	23.15	25,000	578,750	236,635	Aug 06 04:16 PM
MINOGUE MICHAEL R	Chairman, President, CEO	Aug 05	Sale	341.18	25,000	8,529,582	211,635	Aug 06 04:16 PM
MINOGUE MICHAEL R	Chairman, President, CEO	Jun 21	Option Exercise	23.15	25,000	578,750	236,635	Jun 23 04:05 PM
MINOGUE MICHAEL R	Chairman, President, CEO	Jun 21	Sale	325.35	25,000	8,133,702	211,635	Jun 23 04:05 PM
SUTTER MARTIN P	Director	May 19	Sale	267.44	3,750	1,002,900	169,010	May 20 04:28 PM
SUTTER MARTIN P	Director	May 18	Sale	266.72	3,750	1,000,200	172,760	May 20 04:28 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience